Skip to main content
x
About searching

Search results

  1. ESMO 2025 – Lilly strengthens Verzenio’s case

    ESMO 2025 – Lilly strengthens Verzenio’s case … with 85% for the control arm.    Source: ESMO 2025.   The iDFS numbers, meanwhile, continued …

    - 10/17/2025 - 21:46

  2. ESMO 2025 – J&J brings a new Rybrevant use into the fold

    ESMO 2025 – J&J brings a new Rybrevant use into the fold …

    - 10/20/2025 - 12:52

  3. ESMO 2025 – Boehringer and Bayer eye the front line

    ESMO 2025 – Boehringer and Bayer eye the front line … AEs leading to discontinuation 9% 1% Source: ESMO 2025.   As for adverse events, these were said …

    - 10/18/2025 - 13:43

  4. Few pancreatic Gleams of hope for Vyloy

    … 1st-line pancreatic + mFolfirinox Gastric cancer data at ESMO 2025; pancreatic results at a later date ASP2138 …

    - 10/16/2025 - 12:32

  5. ESMO 2025 – Padcev plus Keytruda sets the perioperative bar

    ESMO 2025 – Padcev plus Keytruda sets the perioperative … Notes: *primary endpoint; cutoff date 6 Jun 2025. Source: ESMO 2025.    Keynote-905, also known as EV-303, …

    - 10/19/2025 - 12:25

  6. ESMO 2025 preview – Astra joins the folate fray

    ESMO 2025 preview – Astra joins the folate fray … contender is stepping into the ring. According to an ESMO 2025 abstract, in the phase 1/2 Fontana trial …

    - 10/16/2025 - 14:00

  7. ESMO 2025 preview – first clinical results

    ESMO 2025 preview – first clinical results …

    - 10/15/2025 - 09:57

  8. ESMO 2025 preview – Astellas's third Claudin18.2 shot

    ESMO 2025 preview – Astellas's third Claudin18.2 shot …

    - 10/14/2025 - 17:21

  9. ESMO 2025 preview – Sanofi’s lead shot gets a boost

    ESMO 2025 preview – Sanofi’s lead shot gets a boost … N 36 26 Venue ASCO 2024 ESMO 2025 Cutoff date 28 May 2024 TBD …

    - 10/13/2025 - 11:19

  10. ESMO 2025 preview – Junshi goes pivotal in PI3Kα

    ESMO 2025 preview – Junshi goes pivotal in PI3Kα …

    - 10/10/2025 - 12:53